COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program
05/09/2019
CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the recipients of Route 79, The Duchenne [...]
Neoleukin Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/09/2019
SEATTLE, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”) (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, [...]
Caladrius Biosciences to Participate at the Upcoming September Conferences
05/09/2019
BASKING RIDGE, N.J., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements [...]
Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference
05/09/2019
HINGHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- At the upcoming Rodman & Renshaw Global Investment Conference, Harel Gadot, CEO, President and Chairman of Microbot Medical Inc. (Nasdaq: MBOT), will demonstrate a [...]
Trevi Therapeutics to Participate in Panel Discussion at BTIG Pain / Pruritus Management Forum
05/09/2019
NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious [...]
Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments
05/09/2019
-- Achieved First Quarter Revenue of $15.3 Million; Reaffirms Fiscal 2020 Projected Revenue of $64 to $67 Million -- -- Signed Two Contract Manufacturing Agreements with New and Existing Customers -- TUSTIN, Calif., [...]
Alder BioPharmaceuticals® to Showcase Data from Migraine Prevention Portfolio at 19th Congress of the International Headache Society
05/09/2019
- Data analyses from clinical trials to highlight eptinezumab’s efficacy and early, sustained quality of life improvements in the prevention of chronic migraine - - Preclinical data also to be presented for ALD1910, [...]
Neon Therapeutics Announces Publication in Immunity of Novel Approach to Predict MHC Class II Cancer-Specific Neoantigens
05/09/2019
Proprietary class II prediction tool achieved up to a 61-fold improvement in predicting MHC class II peptides compared to standard methods Proprietary capabilities to be integrated into Neon’s RECON® bioinformatics [...]
BridgeBio Pharma’s Origin Biosciences Presents New Data on the Natural History of Molybdenum Cofactor Deficiency (MoCD) Type A at the Society of the Study of Inborn Errors of Metabolism (SSIEM) Conference
05/09/2019
This landmark study is a comprehensive global survey of the natural history of MoCD Type A Results continue to suggest urgent need for new therapies in MoCD Type A, with median survival of <4 years and rapid disease [...]
Align Technology Announces National Sponsorship With Life Time
05/09/2019
Premier brands join forces to promote the benefits of health and wellness and a better smile with Invisalign ® clear aligners SAN JOSE, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN), [...]
Rise In Mergers And Acquisitions Within Cannabis Industry Continues While Fueling Positive Retail Sales
05/09/2019
Financialnewsmedia.com News Commentary PALM BEACH, Fla., Sept. 05, 2019 (GLOBE NEWSWIRE) -- According to the Marijuana Business Factbook, an exclusive report by Marijuana Business Daily (MJD) containing market [...]
Newly Published Findings Validate Intrommune’s Approach to Treating Peanut and Other Food Allergies
05/09/2019
New York, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , a New York-based biotechnology company developing a patient-friendly immunotherapy platform for the treatment of peanut and other food allergies, is [...]
Prolaris® Test Identifies Men with Prostate Cancer Who Can Safely Defer Treatment
05/09/2019
65 Percent of Patients Remained on Active Surveillance for More than Four Years SALT LAKE CITY, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in [...]
PSI Names New CIO to its Senior Leadership Team
05/09/2019
Industry Veteran Brings 39 Years of IT and Software Development Experience ARLINGTON, Va., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI)—a leading provider of IT solutions to the federal [...]
Roots of Hope national suicide prevention project launched in Ottawa today
05/09/2019
From Mental Health Commission of Canada OTTAWA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Today the Mental Health Commission of Canada (MHCC) officially launched the national Roots of Hope suicide prevention project in Ottawa [...]
Le projet national de prévention du suicide « Enraciner l’espoir » est lancé aujourd’hui à Ottawa
05/09/2019
De Commission de la santé mentale du Canada OTTAWA, 05 sept. 2019 (GLOBE NEWSWIRE) -- Aujourd’hui, la Commission de la santé mentale du Canada (CSMC) a officiellement lancé à Ottawa le projet national de prévention du [...]
Agritek Holdings, Inc. Announces Intent to File Quarterly Report Ending June 30th 2019, Return to Fully Reporting Status, and Registration Statement for Up to Five Million Dollars in Equity Funding
05/09/2019
LOS ANGELES, CA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
B. Braun Successfully Integrates with West-Com at Fairchild Medical Center
05/09/2019
BETHLEHEM, Pa., Sept. 05, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced the integration of their Space™ Infusion Pump Systems with West-Com Nurse Call Systems, Inc. at Fairchild Medical Center, located in [...]
OSE Immunotherapeutics Reports First Half 2019 Results and Provides a Corporate Update
05/09/2019
Major clinical progress with four differentiated therapeutic programs in immuno-oncology and autoimmune diseases; Received €25 M in milestones from collaborations with Servier and Boehringer Ingelheim €16 M turnover and [...]

Pages